LTRN (STOCKS)
Lantern Pharma Inc. Common Stock
$2.690000
-0.160000 (-5.61%)
Prev close: $2.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Panna L. Sharma
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $29.86M
- Employees
- 24
- P/E (TTM)
- -1.53
- P/B (TTM)
- 3.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.39 | $-0.48 | +0.0894 | +18.65% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.49 | +0.0947 | +19.14% |
|
Mar 2025 (Q1)
|
$-0.42 | $-0.50 | +0.0798 | +15.97% |
|
Dec 2024 (Q4)
|
$-0.54 | $-0.52 | -0.0198 | -3.81% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $19.67M |
| Depreciation and Amortization | $17.75K |
| Research and Development | $13.04M |
| Other Operating Expenses | $6.62M |
| Operating Income/Loss | -$19.67M |
| Income/Loss From Continuing Operations After Tax | -$18.92M |
| Income/Loss From Continuing Operations Before Tax | -$18.92M |
| Net Income/Loss | -$18.92M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.92M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.75 |
| Diluted Earnings Per Share | -$1.75 |
| Basic Average Shares | 10,808,430 |
| Diluted Average Shares | 10,808,430 |
| Assets | $13.63M |
| Current Assets | $13.46M |
| Noncurrent Assets | $165.81K |
| Fixed Assets | $35.98K |
| Other Non-current Assets | $129.83K |
| Liabilities | $4.04M |
| Current Liabilities | $4.04M |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.59M |
| Liabilities And Equity | $13.63M |
| Net Cash Flow From Operating Activities | -$16.86M |
| Net Cash Flow From Operating Activities, Continuing | -$16.86M |
| Net Cash Flow From Investing Activities | $16.21M |
| Net Cash Flow From Investing Activities, Continuing | $16.21M |
| Net Cash Flow From Financing Activities | $971.78K |
| Net Cash Flow From Financing Activities, Continuing | $971.78K |
| Net Cash Flow | $323.41K |
| Net Cash Flow, Continuing | $323.41K |
| Comprehensive Income/Loss | -$18.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.85M |
| Other Comprehensive Income/Loss | $65.60K |